Researchers unveil Adaptive-SN2N, a self-supervised deep learning framework that suppresses background artifacts in super-resolution fluorescence microscopy images.
Key Details
- 1Adaptive-SN2N combines risk-aware adaptive normalization with self-supervised learning and Gaussian-weighted overlap inference.
- 2The framework addresses artifact generation by dynamically selecting normalization strategies based on patch statistics (mean, std, skewness).
- 3It demonstrates significant artifact reduction and improved fidelity in both structured illumination microscopy (SIM) and spinning-disk SIM (SD-SIM) datasets.
- 4Adaptive-SN2N improves segmentation and connectivity detection for live-cell mitochondrial and endoplasmic reticulum imaging.
- 5The method enables 1–2 orders of magnitude greater photon efficiency, enhancing live-cell imaging by reducing phototoxicity and maintaining high SNR.
- 6Broad applicability is anticipated for quantitative image analysis tasks such as segmentation and colocalization.
Why It Matters
Artifact suppression is a longstanding challenge for AI-based microscopy and radiology tools, impacting the accuracy and reliability of quantitative analyses. Adaptive-SN2N’s risk-aware approach can drive more trustworthy interpretations in biomedical imaging and opens doors for safer, high-quality live-cell investigations.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.